Photo from wikipedia
MRI‐targeted biopsy (MRTB) improves the clinically significant prostate cancer (csPCa) detection rate with fewer biopsy cores in men with suspected PCa. However, whether concurrent systematic biopsy (SB) can be avoided… Click to show full abstract
MRI‐targeted biopsy (MRTB) improves the clinically significant prostate cancer (csPCa) detection rate with fewer biopsy cores in men with suspected PCa. However, whether concurrent systematic biopsy (SB) can be avoided in patients undergoing MRTB remains unclear.
Keywords:
prostate cancer;
significant prostate;
systematic biopsy;
clinically significant;
biopsy
Journal Title: Journal of Magnetic Resonance Imaging
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Magnetic Resonance Imaging
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!